What was the approved sale price of Advanced Medical Solutions Group to H.B. Fuller, and when does H.B. Fuller expect to close the deal?

Advanced Medical Solutions Group shareholders approved the sale to H.B. Fuller for 715 million pounds, and H.B. Fuller aims to close the deal by year-end.

How will the acquisition of AMS enhance H.B. Fuller's medical business, and what financial impact is expected?

The acquisition will significantly expand H.B. Fuller's medical unit by integrating AMS's tissue-healing technologies, formulated biosurgicals, and mechanical closures; it is expected to generate about $55 million in synergies and increase medical sales to 10% of H.B. Fuller's total business.

AMS Shareholders Approve Sale to H.B. Fuller

Aug 14, 2026

Advanced Medical Solutions Group shareholders approved the sale to H.B. Fuller for £715 million. The acquisition expands H.B. Fuller's medical unit with tissue-healing technologies and targets $55 million in synergies within the medical adhesives market.

MedTech Dive

2026-05-26

Activist Ancora Pushes H.B. Fuller to Drop Bid for UK’s AMS

2026-05-26

Cleveland-based activist Ancora pushes H.B. Fuller to drop bid for U.K. firm

2026-05-26

Ancora Urges H.B. Fuller to Abandon Pursuit of Advanced Medical Solutions Acquisition

2026-05-28

H.B. Fuller Announces New Coating to Improve Food Packaging Recyclability

2026-05-30

Activist Investor Ancora Urges HB Fuller to Abandon UK AMS Acquisition Bid